Pups' weight but not litter size is decreased by prenatal exposure to arsenic. by Andrea A. Cronican (284716)

“…<p><b>A</b>. The mean weight of the pups is decreased approximately by 10% in arsenic treated mothers. …”

Results from Random Forest of Mean Decrease Gini values that tell us the relative importance of different ASVs to the classification processes into low Vs high intake for both prot... by Elvia Ramírez-Carrillo (5518724)

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

MMP-2 production is decreased following ALK5 inhibition. by Rebecca A. Scott (488956)

HFDs increase energy expenditure while decreasing spontaneous activity. by Pamela A. Kakimoto (6294206)

Effect of decreased endogenous betaglycan expression on metanephric development and glomerulogenesis. by Kenneth A. Walker (280683)

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

Group A example; CCL4 (MIP-1ß): Temporal pattern of protein expression level (mean NPX ± 0.95 CI) for C-C motif chemokine ligand 4 (CCL4) a.k.a. macrophage inflammatory protein-1ß... by Pavlos Vlachogiannis (12289810)

“…<p>Statistically significant early peak (mean day 1 vs day 4 values = 6,86 vs 5,46; p<0,005) but no significantly decreasing trend since values seemed to stabilize between day 4 and 10 (5,46 vs 5,33; p = 0,52).…”

CaMKKβ is involved in ST2-104-regulated decrease in autophagy. by Yingshi Ji (9013004)

CaMKKβ contributes to the decrease in apoptosis conferred by ST2-104. by Yingshi Ji (9013004)

Rhinorrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Vomit-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Symptoms free-days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Nausea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Cough-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

Dyspnea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”

<i>P</i>. <i>yoelii</i> infection increases plasma cell apoptosis, decreases plasma cell BAFF-R and increases circulating BAFF concentrations. by Simran Banga (227952)

Mean and standard deviation of vascular density. by Beatriz Cordon (9745619)

Mean and standard deviation of vascular density. by Beatriz Cordon (9745619)